Biology Reference
In-Depth Information
Pinter, A., Kopelman, R., Li, Z., Kayman, S. C., and Sanders, D. A. (1997). Localization of the labile
disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a
highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide
exchange enzymes. J. Virol. 71, 8073-8077.
Pizzato, M., Marlow, S. A., Blair, E. D., and Takeuchi, Y. (1999). Initial binding of murine leukemia
virus particles to cells does not require specific Env-receptor interaction. J. Virol. 73, 8599-8611.
Pizzato, M., Blair, E. D., Fling, M., Kopf, J., Tomassetti, A., Weiss, R. A., and Takeuchi, Y. (2001).
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.. Gene Ther. 8,
1088-1096.
Pizzato, M., Popova, E., and Gottlinger, H. G. (2008). Nef can enhance the infectivity of receptor-
pseudotyped human immunodeficiency virus type 1 particles. J. Virol. 82, 10811-10819.
Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., and Kabat, D. (1998). Effects of CCR5 and
CD4 cell surface concentrations on infections by macrophagetropic isolates of human immuno-
deficiency virus type 1.
J. Virol. 72, 2855-2864.
Ploss, A., and Rice, C. M. (2009). Human occludin is a hepatitis C virus entry factor required for
infection of mouse cells.
EMBO Rep. 10, 1220-1227.
Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., and Rice, C. M. (2009).
Towards a small animal model for hepatitis C.
Nature 457, 882-886.
Pohlmann, S., Soilleux, E. J., Baribaud, F., Leslie, G. J., Morris, L. S., Trowsdale, J., Lee, B.,
Coleman, N., and Doms, R. W. (2001). DC-SIGNR, a DC-SIGN homologue expressed in
endothelial cells, binds to human and simian immunodeficiency viruses and activates infection
in trans.
Proc. Natl. Acad. Sci. USA 98, 2670-2675.
Porotto, M., Yokoyama, C. C., Palermo, L. M., Mungall, B., Aljofan, M., Cortese, R., Pessi, A., and
Moscona, A. (2010). Viral entry inhibitors targeted to the membrane site of action.
J. Virol. 84,
6760-6768.
Pullikotil, P., Vincent, M., Nichol, S. T., and Seidah, N. G. (2004). Development of protein-based
inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral
glycoprotein. J. Biol. Chem. 279, 17338-17347.
Purtscher, M., Trkola, A., Gruber, G., Buchacher, A., Predl, R., Steindl, F., Tauer, C., Berger, R.,
Barrett, N., Jungbauer, A., et al. (1994). A broadly neutralizing human monoclonal antibody against
gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 10, 1651-1658.
Qiu, Z., Hingley, S. T., Simmons, G., Yu, C., Das Sarma, J., Bates, P., and Weiss, S. R. (2006).
Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type
2 spike-mediated entry. J. Virol. 80, 5768-5776.
Quigley, J. G., Burns, C. C., Anderson, M. M., Lynch, E. D., Sabo, K. M., Overbaugh, J., and
Abkowitz, J. L. (2000). Cloning of the cellular receptor for feline leukemia virus subgroup C
(FeLV-C), a retrovirus that induces red cell aplasia. Blood 95, 1093-1099.
Quinn, K., Brindley, M. A., Weller, M. L., Kaludov, N., Kondratowicz, A., Hunt, C. L., Sinn, P. L.,
McCray, P. B., Jr., Stein, C. S., Davidson, B. L., Flick, R., Mandell, R.,
. (2009). Rho GTPases
modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.
et al
J. Virol. 83,
10176-10186.
Rapaport, D., Ovadia, M., and Shai, Y. (1995). A synthetic peptide corresponding to a conserved
heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with
functional domains of other viruses.
EMBO J. 14, 5524-5531.
Rasko, J. E., Battini, J. L., Gottschalk, R. J., Mazo, I., and Miller, A. D. (1999). The RD114/simian
type D retrovirus receptor is a neutral amino acid transporter.
Proc. Natl. Acad. Sci. USA 96,
2129-2134.
Rein, A., Mirro, J., Haynes, J. G., Ernst, S. M., and Nagashima, K. (1994). Function of the
cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the
membrane fusion capability of the murine leukemia virus env protein.
J. Virol. 68, 1773-1781.
